We are live on ! Find out more
BA

BlackRock Advisors Portfolio holdings

AUM $98.8B
1-Year Est. Return 15.8%
This Fund
S&P 500
This Quarter Est. Return
+1.95%
1 Year Est. Return
+15.8%
3 Year Est. Return
+32.35%
5 Year Est. Return
10 Year Est. Return
AUM
$97.6B
AUM Growth
-$1.7B
Cap. Flow
-$3.16B
Cap. Flow %
-3.24%
Top 10 Hldgs %
14.39%
Holding
3,772
New
78
Increased
2,174
Reduced
812
Closed
154

Top Sells

Rank Stock Value
1
CVX icon
Chevron
CVX
+$382M
2
HSP
HOSPIRA INC
HSP
+$235M
3
MRK icon
Merck
MRK
+$227M
4
AGN
Allergan Inc
AGN
+$199M
5
AXP icon
American Express
AXP
+$187M

Sector Composition

Rank Sector Weight
1 Healthcare 19.47%
2 Financials 16.8%
3 Industrials 9.81%
4 Technology 8.84%
5 Energy 7.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DK icon
1276
Delek US
DK
$3.85B
$1.68M ﹤0.01%
42,263
+11,514
+37% +$381K
HRI icon
1277
Herc Holdings
HRI
$4.95B
$1.68M ﹤0.01%
25,836
-176
-0.7% -$11.8K
CEO
1278
DELISTED
CNOOC Limited
CEO
$1.67M ﹤0.01%
11,800
LPSN icon
1279
LivePerson
LPSN
$22.9M
$1.67M ﹤0.01%
10,893
+8,936
+457% +$1.51M
CTB
1280
DELISTED
Cooper Tire & Rubber Co.
CTB
$1.67M ﹤0.01%
39,030
+8,412
+27% +$311K
AMSG
1281
DELISTED
Amsurg Corp
AMSG
$1.67M ﹤0.01%
27,159
+5,276
+24% +$305K
WNR
1282
DELISTED
Western Refining Inc
WNR
$1.66M ﹤0.01%
33,531
-68,668
-67% -$2.87M
CAKE icon
1283
Cheesecake Factory
CAKE
$4.42B
$1.66M ﹤0.01%
33,547
+7,645
+30% +$386K
MDSO
1284
DELISTED
Medidata Solutions, Inc.
MDSO
$1.66M ﹤0.01%
33,746
+4,752
+16% +$220K
CYTK icon
1285
Cytokinetics
CYTK
$10.8B
$1.65M ﹤0.01%
243,562
-2,306
-0.9% -$17.2K
HBIO icon
1286
Harvard Bioscience
HBIO
$26.7M
$1.65M ﹤0.01%
28,376
-272
-0.9% -$14.6K
PKY
1287
DELISTED
Parkway, Inc.
PKY
$1.65M ﹤0.01%
94,892
+20,777
+28% +$370K
ASCMA
1288
DELISTED
Ascent Capital Group, Inc. Series A
ASCMA
$1.65M ﹤0.01%
41,332
-7,195
-15% -$320K
ALGT icon
1289
Allegiant Air
ALGT
$2.73B
$1.64M ﹤0.01%
8,539
+1,241
+17% +$222K
YELP icon
1290
Yelp
YELP
$1.51B
$1.64M ﹤0.01%
34,628
+25,600
+284% +$1.27M
PNR icon
1291
Pentair
PNR
$10.8B
$1.63M ﹤0.01%
38,695
-102
-0.3% -$4.44K
BID
1292
DELISTED
Sotheby's
BID
$1.63M ﹤0.01%
38,628
+5,658
+17% +$241K
CHD icon
1293
Church & Dwight Co
CHD
$23.7B
$1.63M ﹤0.01%
38,040
-722
-2% -$30.1K
SLXP
1294
DELISTED
SALIX PHARMACEUTICALS LTD DEL
SLXP
$1.62M ﹤0.01%
9,366
-152,153
-94% -$22.3M
PCG icon
1295
PG&E
PCG
$39.2B
$1.61M ﹤0.01%
30,298
-2,411
-7% -$133K
TDG icon
1296
TransDigm Group
TDG
$73.2B
$1.59M ﹤0.01%
7,289
SUSQ
1297
DELISTED
SUSQUEHANNA BANCSHARES INC
SUSQ
$1.59M ﹤0.01%
116,132
+4,235
+4% +$56.4K
DGI
1298
DELISTED
DigitalGlobe Inc.
DGI
$1.59M ﹤0.01%
46,715
+6,948
+17% +$217K
MKL icon
1299
Markel Group
MKL
$25.5B
$1.59M ﹤0.01%
2,064
LIOX
1300
DELISTED
Lionbridge Technologies
LIOX
$1.58M ﹤0.01%
276,548
+3,708
+1% +$20.4K

Similar funds

BlackRock Advisors's Q1 2015 Portfolio in Review

As of Q1 2015, BlackRock Advisors held 3,772 positions worth $97.6B, down 1.7% from $99.3B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

BlackRock Advisors withdrew a net $3.16B in Q1 2015, closing 154 positions and reducing 812 holdings. Its most notable exit was Allergan Inc, an estimated $199M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 17% a quarter earlier, followed by Financials and Industrials.

Against the trend, BlackRock Advisors opened a new position in Mobileye N.V. worth $252M.

  • BlackRock Advisors's largest Q1 2015 buy was Mobileye N.V.: 6,000,666 shares worth $252M.
  • BlackRock Advisors added most to UnitedHealth in Q1 2015, an estimated $461M increase.
  • BlackRock Advisors's biggest Q1 2015 reduction was Chevron, cutting an estimated $382M.
  • BlackRock Advisors fully exited Allergan Inc in Q1 2015, selling an estimated $199M.
  • BlackRock Advisors's ten largest holdings make up 14% of its $97.6B portfolio in Q1 2015.
  • BlackRock Advisors opened 78 new positions and closed 154 in Q1 2015.
  • BlackRock Advisors's portfolio value fell 1.7% quarter-over-quarter to $97.6B.

Based on BlackRock Advisors's 13F filing for Q1 2015, filed 13 May 2015.